AAM
MDGL icon

AMI Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

AMI Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
2,135
-478
-18% -$245K 0.07% 48
2026
Q1 		$1.37M Sell
2,613
-139
-5% -$66.4K 0.09% 39
2025
Q4 		$1.6M Sell
2,752
-674
-20% -$344K 0.09% 43
2025
Q3 		$1.57M Sell
3,426
-14
-0.4% -$5.22K 0.09% 44
2025
Q2 		$1.04M Sell
3,440
-2,060
-37% -$614K 0.06% 49
2025
Q1 		$1.82M Buy
5,500
+522
+10% +$172K 0.11% 48
2024
Q4 		$1.54M Sell
4,978
-35
-0.7% -$9.84K 0.08% 51
2024
Q3 		$1.06M Sell
5,013
-472
-9% -$121K 0.06% 66
2024
Q2 		$1.54M Sell
5,485
-4,133
-43% -$984K 0.08% 51
2024
Q1 		$2.57M Buy
9,618
+4,845
+102% +$1.14M 0.13% 62
2023
Q4 		$1.1M Buy
+4,773
New +$835K 0.06% 69

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AMI Asset Management's MDGL Position: Q2 2026 in Review

AMI Asset Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 18% in Q2 2026, selling an estimated $245K and leaving 2,135 shares worth $1.15M. The position accounts for 0.07% of the portfolio, ranked #48.

AMI Asset Management first reported a position in MDGL in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.57M in Q1 2024. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • AMI Asset Management held 2,135 shares of Madrigal Pharmaceuticals worth $1.15M as of Q2 2026.
  • AMI Asset Management sold 478 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $245K.
  • Madrigal Pharmaceuticals made up 0.07% of AMI Asset Management's portfolio in Q2 2026, its #48 holding.
  • AMI Asset Management first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • AMI Asset Management's Madrigal Pharmaceuticals position peaked at $2.57M in Q1 2024.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on AMI Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.